Highlights on distinctive structural and functional properties of HTLV Tax proteins

Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pa...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 4; p. 271
Main Authors Romanelli, Maria Grazia, Diani, Erica, Bergamo, Elisa, Casoli, Claudio, Ciminale, Vincenzo, Bex, Françoise, Bertazzoni, Umberto
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear factor kappa-B) pathway, and interactions with host factors.
AbstractList Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear factor kappa-B) pathway, and interactions with host factors.
Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear factor kappa-B) pathway, and interactions with host factors.
Human T-cell Leukemia Viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or -4 . HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T-cell leukemia (ATL) and of HTLV associated myelopathy/tropical spastic paraparesis (HAM/TSP), whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-kB pathway, and interactions with host factors.
Author Romanelli, Maria Grazia
Ciminale, Vincenzo
Casoli, Claudio
Bergamo, Elisa
Bertazzoni, Umberto
Bex, Françoise
Diani, Erica
AuthorAffiliation 1 Department of Life and Reproduction Sciences, University of Verona Verona, Italy
2 GEMIB laboratory, Center for Medical Research and Molecular Diagnostics Parma, Italy
4 Institute for Microbiological Research J-M Wiame, Laboratory of Microbiology, Université Libre de Bruxelles Brussels, Belgium
3 Department of Surgery, Oncology and Gastroenterology, University of Padua Padua, Italy
AuthorAffiliation_xml – name: 1 Department of Life and Reproduction Sciences, University of Verona Verona, Italy
– name: 4 Institute for Microbiological Research J-M Wiame, Laboratory of Microbiology, Université Libre de Bruxelles Brussels, Belgium
– name: 2 GEMIB laboratory, Center for Medical Research and Molecular Diagnostics Parma, Italy
– name: 3 Department of Surgery, Oncology and Gastroenterology, University of Padua Padua, Italy
Author_xml – sequence: 1
  givenname: Maria Grazia
  surname: Romanelli
  fullname: Romanelli, Maria Grazia
  organization: Department of Life and Reproduction Sciences, University of Verona Verona, Italy
– sequence: 2
  givenname: Erica
  surname: Diani
  fullname: Diani, Erica
– sequence: 3
  givenname: Elisa
  surname: Bergamo
  fullname: Bergamo, Elisa
– sequence: 4
  givenname: Claudio
  surname: Casoli
  fullname: Casoli, Claudio
– sequence: 5
  givenname: Vincenzo
  surname: Ciminale
  fullname: Ciminale, Vincenzo
– sequence: 6
  givenname: Françoise
  surname: Bex
  fullname: Bex, Françoise
– sequence: 7
  givenname: Umberto
  surname: Bertazzoni
  fullname: Bertazzoni, Umberto
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24058363$$D View this record in MEDLINE/PubMed
BookMark eNpVkctPGzEQhy1EBRS4c0J77CWpH2vv-oJUobZBitRD04qb5bXHwWhjB9uL2v--TkIRWPJrHt-M_fuIjkMMgNAVwXPGevnZbbwZ5hQTNseYduQInREh2hnD9P74zfkUXeb8iOtoMa3rCTqlLeY9E-wM_Vz49cNYZ8lNDI31ufhgin-GJpc0mTIlPTY62MZNO3sM9bpNcQupeKg5rlmslr-blf6zMxfwIV-gD06PGS5f9nP069vX1e1itvzx_e72y3JmOO3LzBiCBz4YxvtB9K3DnSDCtOCMNrwnEgjr-sHxYTCYWNsyCQ4Ys4676uSWnaO7A9dG_ai2yW90-qui9mpviGmtdO3SjKAkqxAL3FnCW2KplNRZYesXaC2kI5V1c2Btp2ED1kAo9eHvoO89wT-odXxWrBOip10FfHoBpPg0QS5q47OBcdQB4pRVrYsJlpLxGooPoSbFnBO41zIEq520ai-t2kmr9tLWlOu37b0m_BeS_QPcR6R3
CitedBy_id crossref_primary_10_2336_nishinihonhifu_79_492
crossref_primary_10_3390_v13112221
crossref_primary_10_1038_aps_2017_17
crossref_primary_10_1128_JVI_01311_19
crossref_primary_10_3390_pathogens8040290
crossref_primary_10_1074_jbc_M115_684746
crossref_primary_10_1128_JVI_00853_17
crossref_primary_10_1016_j_virusres_2019_02_007
crossref_primary_10_1182_blood_2014_04_572750
crossref_primary_10_1016_j_bbamcr_2014_08_004
crossref_primary_10_1016_j_ajps_2021_08_004
crossref_primary_10_3389_fmicb_2019_01958
crossref_primary_10_3390_ijms222413597
crossref_primary_10_1186_s12977_019_0467_0
crossref_primary_10_3390_v6103925
crossref_primary_10_3389_fmicb_2018_00080
crossref_primary_10_1007_s13311_016_0450_6
crossref_primary_10_3390_ijms23147583
crossref_primary_10_3389_fmicb_2014_00398
crossref_primary_10_1002_jmv_24342
crossref_primary_10_1128_JVI_03113_15
crossref_primary_10_3390_cancers14030537
crossref_primary_10_3389_fmicb_2018_00285
crossref_primary_10_3390_ijms22158001
crossref_primary_10_3389_fmicb_2014_00792
crossref_primary_10_1186_s12977_015_0185_1
crossref_primary_10_3389_fmicb_2018_01215
crossref_primary_10_3389_fmicb_2019_01302
crossref_primary_10_1007_s11481_018_9784_7
crossref_primary_10_1016_j_virol_2014_12_005
crossref_primary_10_1016_j_biopha_2018_10_139
crossref_primary_10_1128_MCB_00450_16
crossref_primary_10_1186_s12977_014_0093_9
crossref_primary_10_1371_journal_ppat_1004575
crossref_primary_10_5306_wjco_v7_i1_54
crossref_primary_10_1002_rmv_1988
crossref_primary_10_1016_j_semcancer_2019_10_005
crossref_primary_10_1186_s12977_020_00538_w
ContentType Journal Article
Copyright Copyright © Romanelli, Diani, Bergamo, Casoli, Ciminale, Bex and Bertazzoni. 2013
Copyright_xml – notice: Copyright © Romanelli, Diani, Bergamo, Casoli, Ciminale, Bex and Bertazzoni. 2013
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fmicb.2013.00271
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
EndPage 271
ExternalDocumentID oai_doaj_org_article_93bc0de5fd1541d2992fd6d363aa69f1
10_3389_fmicb_2013_00271
24058363
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
GROUPED_DOAJ
GX1
HYE
IAO
IHR
IPNFZ
KQ8
M48
M~E
NPM
O5R
O5S
OK1
PGMZT
RIG
RNS
RPM
AAYXX
AFPKN
CITATION
ECGQY
IEA
7X8
5PM
ID FETCH-LOGICAL-c528t-cc10b5bc358b684f07616c4efcac5819e1378bf5bbc01dd439efe33df5f19e5d3
IEDL.DBID RPM
ISSN 1664-302X
IngestDate Tue Oct 22 15:12:55 EDT 2024
Tue Sep 17 21:19:26 EDT 2024
Fri Oct 25 06:05:59 EDT 2024
Thu Sep 26 17:09:44 EDT 2024
Tue Oct 15 23:49:36 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords NF-κB
signal transduction
HTLV
Tax proteins
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c528t-cc10b5bc358b684f07616c4efcac5819e1378bf5bbc01dd439efe33df5f19e5d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Jun-ichi Fujisawa, Kansai Medical University, Japan; Makoto Yamagishi, The University of Tokyo, Japan; Yorifumi Satou, Kumamoto University, Japan
Edited by: Akio Adachi, The University of Tokushima Graduate School, Japan
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766827/
PMID 24058363
PQID 1540109935
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_93bc0de5fd1541d2992fd6d363aa69f1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3766827
proquest_miscellaneous_1540109935
crossref_primary_10_3389_fmicb_2013_00271
pubmed_primary_24058363
PublicationCentury 2000
PublicationDate 2013-09-09
PublicationDateYYYYMMDD 2013-09-09
PublicationDate_xml – month: 09
  year: 2013
  text: 2013-09-09
  day: 09
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in microbiology
PublicationTitleAlternate Front Microbiol
PublicationYear 2013
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References 15236397 - Ann Neurol. 2004 Jul;56(1):10-9
1736534 - Virology. 1992 Mar;187(1):316-20
16155610 - Oncogene. 2005 Sep 5;24(39):6035-46
22264793 - Cancer Cell. 2012 Jan 17;21(1):121-35
7637025 - J Virol. 1995 Sep;69(9):5806-11
23162541 - Front Microbiol. 2012 Nov 15;3:388
9630230 - Cell. 1998 May 29;93(5):875-84
7579327 - Blood. 1995 Nov 15;86(10):3619-39
23279616 - Cancer Sci. 2013 Mar;104(3):313-20
22911729 - PLoS One. 2012;7(7):e41003
21994745 - Viruses. 2011 May;3(5):541-60
16550188 - Nat Med. 2006 Apr;12(4):466-72
17097489 - J Heart Lung Transplant. 2006 Nov;25(11):1277-82
21813598 - J Virol. 2011 Oct;85(20):10719-29
21119600 - Oncogene. 2011 Mar 24;30(12 ):1379-89
22865346 - Protein Cell. 2012 Aug;3(8):581-9
7745688 - J Virol. 1995 Jun;69(6):3420-32
9325311 - J Biol Chem. 1997 Oct 10;272(41):25816-23
17986383 - Biochem Biophys Res Commun. 2008 Jan 4;365(1):189-94
20875659 - Virology. 2010 Dec 5;408(1):39-48
17715223 - J Virol. 2007 Nov;81(21):11900-7
16007163 - Oncogene. 2005 Oct 6;24(44):6719-28
23622267 - Retrovirology. 2013 Apr 26;10:47
18287238 - J Virol. 2008 May;82(9):4343-53
19782779 - Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):266-74
23049525 - Front Microbiol. 2012 Sep 21;3:333
9209279 - Leukemia. 1997 Apr;11 Suppl 3:3-6
20332002 - Mol Aspects Med. 2010 Oct;31(5):350-8
20164218 - J Virol. 2010 May;84(9):4755-68
8599225 - Virology. 1996 Mar 1;217(1):373-9
23198153 - Leuk Res Treatment. 2012;2012:213653
16532031 - Oncogene. 2006 Jul 27;25(32):4470-82
16254341 - J Virol. 2005 Nov;79(22):14069-78
19650892 - Retrovirology. 2009 Aug 03;6:71
22787458 - Front Microbiol. 2012 Jul 09;3:247
1427072 - Genes Dev. 1992 Nov;6(11):2066-76
18456423 - Pathol Biol (Paris). 2009 Mar;57(2):161-6
17363973 - EMBO Rep. 2007 May;8(5):510-5
22127321 - Best Pract Res Clin Haematol. 2011 Dec;24(4):559-65
23135727 - J Virol. 2013 Jan;87(2):1123-36
21994719 - Viruses. 2010 Sep;2(9):2037-77
21917984 - J Virol. 2011 Dec;85(23):12673-85
23213551 - Leuk Res Treatment. 2012;2012:876153
11861831 - J Virol. 2002 Mar;76(6):2648-53
17483473 - Proc Natl Acad Sci U S A. 2007 May 8;104(19):8035-40
11402335 - Oncogene. 2001 Apr 30;20(19):2390-400
10557085 - Oncogene. 1999 Oct 28;18(44):5967-72
16551350 - Retrovirology. 2006 Mar 21;3:20
11244044 - Annu Rev Immunol. 2001;19:475-96
16340481 - J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):100-6
18509526 - PLoS One. 2008 May 28;3(5):e2251
8621651 - J Biol Chem. 1996 Apr 19;271(16):9730-8
8361755 - Oncogene. 1993 Sep;8(9):2391-7
10438454 - J Biol Chem. 1999 Aug 13;274(33):22911-4
18375384 - J Biol Chem. 2008 Jun 13;283(24):16299-308
16840323 - J Virol. 2006 Aug;80(15):7427-38
20101207 - Oncogene. 2010 Apr 8;29(14):2142-52
10766811 - J Biol Chem. 2000 Apr 21;275(16):11852-7
21969187 - Int J Hematol. 2011 Nov;94(5):430-4
23226145 - Front Microbiol. 2012 Nov 30;3:406
22111594 - Viral Immunol. 2011 Dec;24(6):429-39
19761585 - Retrovirology. 2009 Sep 17;6:83
20512047 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):290-6
9190894 - Oncogene. 1997 Jun 12;14(23):2785-92
11034425 - J Immunol. 2000 Oct 1;165(7):4127-32
11160720 - J Virol. 2001 Mar;75(5):2161-73
20017952 - Retrovirology. 2009 Dec 17;6:117
16155606 - Oncogene. 2005 Sep 5;24(39):5996-6004
16436385 - J Biol Chem. 2006 Mar 31;281(13):8927-38
17384582 - Nat Rev Cancer. 2007 Apr;7(4):270-80
23286582 - Viral Immunol. 2013 Feb;26(1):3-12
16155602 - Oncogene. 2005 Sep 5;24(39):5952-64
21765415 - Nat Immunol. 2011 Jul 17;12 (9):834-43
14530271 - J Biol Chem. 2004 Jan 2;279(1):495-508
19193260 - Emerg Infect Dis. 2009 Feb;15(2):175-84
2871307 - Lancet. 1986 May 3;1(8488):1031-2
21994756 - Viruses. 2011 Jun;3(6):829-57
16767081 - Nat Cell Biol. 2006 Jul;8(7):717-24
20154469 - Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(2):117-30
11070040 - J Virol. 2000 Dec;74(23):11394-7
19195675 - Virology. 2009 Mar 30;386(1):6-11
23577667 - Retrovirology. 2013 Apr 11;10:40
14645559 - J Virol. 2003 Dec;77(24):13028-35
23175371 - J Virol. 2013 Feb;87(3):1699-707
22429853 - Adv Cancer Res. 2012;113:85-120
23633516 - Carcinogenesis. 2013 Sep;34(9):2129-36
12670929 - J Biol Chem. 2003 Jun 13;278(24):21814-22
8602268 - Nature. 1996 Apr 18;380(6575):642-6
16424386 - Blood. 2006 May 15;107(10):4021-9
11971966 - Mol Cell Biol. 2002 May;22(10):3327-38
9765430 - J Virol. 1998 Nov;72(11):8852-60
16042787 - Retrovirology. 2005 Jul 23;2:46
23256545 - Retrovirology. 2012 Dec 21;9:114
23483782 - Front Microbiol. 2013 Mar 08;4:49
15466468 - J Biol Chem. 2004 Dec 17;279(51):52978-83
1351105 - J Virol. 1992 Jul;66(7):4570-5
17337070 - J Virol Methods. 2007 Jun;142(1-2):159-68
23464580 - AIDS Res Hum Retroviruses. 2013 Jul;29(7):1061-7
23507197 - Biochim Biophys Acta. 2013 Jun;1833(6):1542-52
9482110 - Oncogene. 1998 Feb 5;16(5):643-54
16308315 - Carcinogenesis. 2006 Apr;27(4):673-81
19129196 - J Biol Chem. 2009 Mar 6;284(10):6208-17
23217627 - Virology. 2013 Jan 5;435(1):187-99
22891252 - J Biol Chem. 2012 Oct 5;287(41):34683-93
16287853 - Mol Cell Biol. 2005 Dec;25(23):10391-406
15595431 - AIDS Rev. 2004 Jul-Sep;6(3):144-54
3009864 - J Virol. 1986 May;58(2):508-12
12190935 - Immunol Rev. 2002 Jul;185:236-65
21552325 - PLoS Pathog. 2011 Apr;7(4):e1002025
10701997 - Trends Microbiol. 2000 Jan;8(1):8-10
20526659 - Virus Genes. 2010 Oct;41(2):149-57
16337343 - Gene. 2006 Jan 3;365:119-24
16263794 - Blood. 2006 Mar 1;107(5):1980-8
19609363 - PLoS Pathog. 2009 Jul;5(7):e1000521
23217160 - Retrovirology. 2012 Dec 07;9:102
10888626 - J Virol. 2000 Aug;74(15):6866-74
22405461 - Rev Neurol (Paris). 2012 Mar;168(3):257-69
23009565 - Retrovirology. 2012 Sep 25;9:78
18661220 - Virus Genes. 2008 Oct;37(2):231-40
23054433 - Virus Genes. 2013 Feb;46(1):39-46
6981847 - Science. 1982 Nov 5;218(4572):571-3
11264182 - Blood. 2001 Apr 1;97(7):2137-44
9546394 - Cell. 1998 Apr 3;93(1):81-91
18523016 - Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):7959-63
17121800 - J Virol. 2007 Feb;81(4):1690-700
15882466 - Retrovirology. 2005 May 09;2:30
16990599 - Blood. 2007 Feb 1;109(3):1051-60
23206352 - Retrovirology. 2012 Dec 03;9:98
1986467 - Transfusion. 1991 Jan;31(1):67-75
16155601 - Oncogene. 2005 Sep 5;24(39):5938-51
12370815 - Oncogene. 2002 Oct 17;21(47):7241-6
7492783 - Blood. 1995 Dec 1;86(11):4243-9
23009398 - Retrovirology. 2012 Sep 25;9:77
20610824 - Clin Microbiol Rev. 2010 Jul;23(3):577-89
21525354 - J Virol. 2011 Jul;85(13):6212-9
19200568 - Virology. 2009 Mar 30;386(1):68-78
8289813 - Mol Cell Biol. 1994 Feb;14(2):1374-82
15975923 - J Biol Chem. 2005 Aug 19;280(33):29653-60
16809310 - J Virol. 2006 Jul;80(14):7052-9
21054678 - Cancer Sci. 2011 Jan;102(1):260-6
19187529 - Retrovirology. 2009 Feb 02;6:9
15156194 - Oncogene. 2004 Jul 15;23 (32):5447-58
9632633 - J Biol Chem. 1998 Jun 26;273(26):15891-4
23060864 - Front Microbiol. 2012 Sep 17;3:334
23217176 - Retrovirology. 2012 Dec 07;9:103
21953273 - Int J Hematol. 2011 Nov;94(5):435-42
18957425 - J Biol Chem. 2008 Dec 26;283(52):36311-20
23534762 - Asian Pac J Cancer Prev. 2013;14(1):405-8
22740410 - J Virol. 2012 Sep;86(17):9474-83
7936632 - Oncogene. 1994 Nov;9(11):3099-105
14581552 - J Virol. 2003 Nov;77(22):12152-64
21173796 - Cell Res. 2011 Jan;21(1):71-85
8622884 - Oncogene. 1996 Apr 18;12(8):1645-52
15911757 - Proc Natl Acad Sci U S A. 2005 May 31;102(22):7994-9
21736733 - J Transl Med. 2011 Jul 07;9:106
8170951 - Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3584-8
20558150 - Chem Biol Interact. 2010 Nov 5;188(2):359-65
18815299 - J Virol. 2008 Dec;82(23):11939-47
23405243 - PLoS One. 2013;8(2):e55989
8421695 - Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):610-4
15269214 - J Biol Chem. 2004 Oct 8;279(41):43307-20
6261256 - Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
11264418 - Mol Biol Evol. 2001 Apr;18(4):661-71
16285885 - Retrovirology. 2005 Nov 14;2:70
18653454 - J Virol. 2008 Oct;82(19):9359-68
15569604 - Front Biosci. 2005 Jan 01;10:620-42
15310405 - Retrovirology. 2004 Aug 13;1:20
20395415 - Blood. 2010 Jul 8;116(1):54-62
19602711 - Blood. 2009 Sep 17;114(12):2427-38
16973592 - J Virol. 2006 Oct;80(19):9876-88
23606621 - Rev Med Virol. 2013 Sep;23(5):269-80
22819021 - Curr Opin Virol. 2012 Aug;2(4):474-81
8764028 - J Virol. 1996 Aug;70(8):5194-202
7700645 - Oncogene. 1995 Mar 16;10(6):1199-207
References_xml
SSID ssj0000402000
Score 2.2563803
SecondaryResourceType review_article
Snippet Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and...
Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and...
Human T-cell Leukemia Viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 271
SubjectTerms HTLV
Microbiology
NF-kappa B
Signal Transduction
Tax-1
Tax-2
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFBajMNilrPvRee2GBrvsYCpblmQfszSZM7J0JHLJTVi_WC_uWNND__s-SWlJRmGXHXyRJVl8T-i9z3p8D6HPpSDeEu9zXnmSV8KRvKkdz7XW4LBhQ_dReP7Hgrdd9X3N1julvkJOWJIHTsCdNVQbYh3zFsYWFk7P0ltuKczS88Yn4kOaHTIVz-BAiwhJ95LAwhow05XRIZUrKJqWotjzQ1Gu_6kY8-9UyR3fM32JDrdBIx6lxR6hZ254hZ6nMpJ3r9GqnX1r5_DIFb5Y4PPZSgJXl7PLCV7JZTeW3XI0x6PFOZ52i3FSv8U_QwbfUkI0iC-muJXzSyxH69AsJ8Do36BuOpHjNt8WS8gNK-tNbkxBNNOGslrzGoAXvOCmct70hoHbdwUVtfZMA5yFtRCHOO8otZ55eMksfYsOhuvBvUPYlkLUhQl_R30FdLGvGghuNQxrKqF7mqEvD9Cp30kTQwGXCDCrCLMKMKsIc4a-Bmwf-wU169gANlZbG6t_2ThDnx4so2D3hyuNfnDXtzcK-se7PcoydJws9fgpiFVYDXNkSOzZcG8t-2-Gq19RYRtOXV6X4v3_WPwJelHGEhohNe0UHWz-3LoPEMhs9Me4Z-8BWzbrVQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBejZbDL2PeyrUWFXXZwsS1Lsg-lZGlSZ2RpSeSSm7C-tsJwtjSF9r_fk-x2zcixB19kSRbvPen9ftbTE0KfUx47EzsXsczFUcZtHBW5ZZFSChw2GHQdEs9_n7Kyyr4t6OLf8ehOgFdbqZ2_T6pa_Tq8-XN7DBP-yDNO8LeggUutfJSWT1aa-gPlu2kGPN0H8nVgP6zLnirFcbtXubXhhm8KKfy34c7_wycf-KPRC_S8A5K432r-JXpim1foaXu15O1rNC_Hp-UEHjHHZ1N8Mp4L4O9ifDHEczGrBqKa9Se4Pz3Bo2o6aDPi4nMf1TcTgBDx2QiXYnKBRX_hi8UQWP4bVI2GYlBG3QUKkaZpvo60TmJFlSY0VywHZXCWMJ1Zp2tNAQrYhPBcOaqUjhNjAJtYZwkxjjp4SQ15i3aaZWPfI2xSzvNE-z-mLgMKWWcFAF4FzYqMq5r00Jc70cnfbZ4MCfzCi1kGMUsvZhnE3ENfvWzv6_kM16FgufohuwkjCwKDMpY6AzaTGPCaqTPMELCemhUOOjm404yEGeG3OerGLq-vJNQP-32E9tC7VlP3nwL8QnPoo4f4hg43xrL5prn8GbJuw0rM8pR_eIzBf0TP0nCthg9X-4R21qtruwfgZq32g83-BTS78xk
  priority: 102
  providerName: Scholars Portal
Title Highlights on distinctive structural and functional properties of HTLV Tax proteins
URI https://www.ncbi.nlm.nih.gov/pubmed/24058363
https://search.proquest.com/docview/1540109935
https://pubmed.ncbi.nlm.nih.gov/PMC3766827
https://doaj.org/article/93bc0de5fd1541d2992fd6d363aa69f1
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYACamXqoU-ti3ISFx6CCRx_MixIOiqYlGlLtXeLD_LSuCsWCq1_74zzgaxqCcuPsR2Ys2MPfPZk8-EHNayjL6MsRBNLItGhrJoVRCFtRYcNhi0ycTzk0sxvmq-zfhsg_DhX5ictO_s_Cjd3B6l-XXOrVzcuuMhT-z4--QUJoVQgNk3ySYY6COInpdfRERl2R9JAgBrQUNzZzGLC8lMa4mXw4Af44oJtuaNMmn__yLNpwmTjzzQ-SvychU60i_9EF-TjZB2yHZ_meTfXfIDUzZuEGsvaZeox8mb8mpGe5JYJNigJnmKvqzfAqQL3Iu_Q1JV2kU6nl78pFPzh2b2hnlaviFX52fT03GxujKhcLxW94VzVWm5dYwrKxSIX4pKuCZEZxwH5x8qJpWN3FpXVt5DNBJiYMxHHqGSe_aWbKUuhfeE-lpKVTncI40NgEbTtBDiWujWNtIaNiKfB9HpRc-MoQFRoMR1lrhGiess8RE5Qdk-tENO6_ygu_ulV5rVLYNB-cCjByupPPjJOnrhQUvGiDbCSw4GzWiYA3iwYVLofi81tM8nfIyPyLteUw-fGjQ9InJNh2tjWa8Bs8s82ysz-_Dsnh_JizrfnoFZaZ_IFig77EEMc2_3M_aH8uusgnLSqP1sxf8A9f32cw
link.rule.ids 230,315,730,783,787,867,888,2109,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkQvlGdZysNIXDhk68SxnRxLRbXAboXEturNil-wonVW3a0E_PqOnU3VrbjANbYTJ9-MZ8aefAPwrpDUW-p9JkpPs1I6mtWVE5nWGg02CnSTiOcnR2J0XH4-5acbwPt_YVLSvtGzYTg7H4bZj5RbOT83e32e2N7XyQEqhagwZr8Dd1FfaXkjSE8LcIyJKO0OJTEEqxGjmdExjyvSmRYylodBS8YrJtiaPUq0_X_zNW-nTN6wQYfbcNLPvks9-Tm8XOqh-XOL2PGfX-8hPFh5pWS_a34EGy48hntdncrfT-BbzAY5i2H8grSB2LguhLRQko5_NnJ3kCZYEs1kt7tI5nGb_yLytZLWk9F0fEKmzS-SiCFmYfEUjg8_Tg9G2aoaQ2Z4US0zY3KquTaMV1pUiKwUuTCl86YxHP0KlzNZac-1NjS3Fh0d5x1j1nOPjdyyZ7AZ2uCeA7GFlFVu4varLzEebcoavWeNw-pS6oYN4H2PiZp3pBsKg5UIpUpQqgilSlAO4EME7bpfpMtOF9qL72r1VVXNcFLWcW9RAHOLJrjwVliEv2lE7fEmb3vIFapXPDNpgmsvFwr7p8NDxgew04nA9aN6ERqAXBOOtbmstyDkicJ7BfGL_x75Bu6PppOxGn86-rILW0Uq0hGT317CJgLvXqGrtNSvk2JcAVhaFb8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSlPAvL00hcOGTXiWMnOUJhtUBbVWKLKi6Wn7CidVbdrVT49cw4m2q34tRrbCd2vhnPjD36hpC3RcWCYyFksgwsKyvPsqb2MjPGgMEGgdaJeH7_QE6Oyi_H4nit1FdK2rdmNownp8M4-5VyK-endtTniY0O93dBKWQNMfvchdFNcgt0lsm1QD1twhgXMdZdTEIY1gBOM2swlwspTYsKS8SANRM1l3zDJiXq_v_5m1fTJtfs0Pge-dGvoEs_-T08X5qh_XuF3PFaS7xPtlfeKX3fdXlAbvj4kNzu6lX-eUS-YVbICYbzC9pG6nB_iGnDpB0PLXJ4UB0dRXPZnTLSOR73nyFvK20DnUz3vtOpvqCJIGIWF4_J0fjTdHeSraoyZFYU9TKzNmdGGMtFbWQNCFcyl7b0wWorwL_wOa9qE4QxluXOgcPjg-fcBRGgUTi-Q7ZiG_1TQl1RVXVu8Rg2lBCX6rIBL9rAsKasjOYD8q7HRc078g0FQQvCqRKcCuFUCc4B-YDAXfZD2uz0oD37qVZ_VjUcJuW8CA4EMXdgiovgpAMR0Fo2AV7ypoddgZrh3YmOvj1fKOifLhG5GJAnnRhcfqoXowGpNgRkYy6bLQB7ovJewfzs2iNfkzuHH8dq7_PB1-fkbpFqdWAO3AuyBbj7l-AxLc2rpBv_APiHGD8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIGHLIGHTS+ON+DISTINCTIVE+STRUCTURAL+AND+FUNCTIONAL+PROPERTIES+OF+HTLV+TAX+PROTEINS&rft.jtitle=Frontiers+in+microbiology&rft.au=Maria+Grazia+Romanelli&rft.au=Erica+eDiani&rft.au=Elisa+eBergamo&rft.au=Claudio+eCasoli&rft.date=2013-09-09&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-302X&rft.volume=4&rft_id=info:doi/10.3389%2Ffmicb.2013.00271&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_93bc0de5fd1541d2992fd6d363aa69f1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon